Stryker | SYK - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 297M 2M 2026-09
AtriCure USD 1.2M 15K 2026-06
Baxter International USD 64M 14M 2026-06
Becton, Dickinson and Co. USD 132M 17M 2026-06
Boston Scientific USD 100M 4M 2026-09
CONMED USD 11.14M 3.25M 2026-09
Cooper Companies USD 21.5M 600K 2026-06
Danaher USD 135M 28M 2026-09
Dexcom USD 3.1M 100K 2026-09
Edwards Lifesciences USD 30M 5.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 5.08M 2.32M 2026-03
Insulet USD 12.3M 1.3M 2026-09
Integra LifeSciences USD 22.96M 33K 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 43M 25M 2026-03
Medtronic USD 186M 10M 2026-06
Merit Medical Systems USD 7.33M 4.78M 2026-09
Olympus JPY 2.82B 2.31B 2026-06
Smith & Nephew USD 69M 1000K 2025-12
Steris USD 15.8M 700K 2026-06
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 27.95M 2.24M 2026-06
Terumo JPY 1.48B 51M 2026-06
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09